查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1800221

动物寄生虫杀虫剂市场－2025年至2030年的预测

Animal Parasiticides Market - Forecasts fom 2025 to 2030
出版日期: | 出版商: Knowledge Sourcing Intelligence | 英文 147 Pages | 商品交期: 最快1-2个工作天内

价格
简介目录

预计动物寄生虫杀虫剂市场规模将从 2025 年的 131.9 亿美元成长至 2030 年的 172.51 亿美元，复合年增长率为 5.51%。

预计2025年至2030年，兽医驱虫剂市场将经历显着增长，这主要得益于宠物拥有率的上升、兽医医疗保健成本的上涨以及人们对通用感染疾病认识的不断提高。驱虫剂对于控制伴侣动物和农场动物体内外寄生虫至关重要，其需求正在增长，因为它们能够促进动物健康并预防疾病感染。儘管严格的监管政策带来了挑战，但市场正受益于产品开发的技术创新以及政府促进动物福利的措施。

市场驱动因素

兽医杀虫剂市场的主要驱动力是全球宠物拥有量的激增，狗和猫等伴侣动物越来越受到重视，尤其是在都市区。这种趋势增加了对有效杀虫剂的需求，以确保宠物健康并预防可传播给人类的疾病。随着宠物饲主和牲畜生产者投资先进的治疗方法以改善动物福利，动物保健支出的增加（尤其是在已开发地区）进一步推动了市场成长。在政府和动物福利组织的倡议支持下，人们对动物传播疾病的认识不断提高也是一个关键因素。这类宣传活动强调了杀虫剂在控制由跳蚤、蜱虫、蛔虫和其他寄生虫引起的疾病的重要性。此外，旨在加强伴侣动物疾病管理的创新外部杀虫剂的开发透过提供更有效、更有针对性的解决方案来推动市场扩张。

市场限制

由于严格的产品核可监管政策，动物寄生虫杀虫剂市场面临挑战。这些旨在确保安全性和有效性的法规可能会延迟新型寄生虫杀虫剂的上市，并增加开发成本和时间。遵守不同的地区标准进一步增加了製造商（尤其是中小型企业）进入市场的难度。此外，先进寄生虫杀虫剂的高成本可能会限制其在价格敏感型市场（例如新兴市场）的采用。透过简化的监管流程和具有成本效益的技术创新来应对这些挑战，对于市场持续成长至关重要。

目录

第一章执行摘要

第二章市场概述

  • 市场概览
  • 市场定义
  • 调查范围
  • 市场区隔

第三章 经营状况

  • 市场驱动因素
  • 市场限制
  • 市场机会
  • 波特五力分析
  • 产业价值链分析
  • 政策法规
  • 策略建议

第四章 技术展望

第五章动物寄生虫杀虫剂市场（依产品类型）

  • 介绍
  • 杀外寄生虫剂
  • 体内杀寄生虫剂
  • Endectocides

第六章：动物寄生虫杀虫剂市场（以寄生虫类型）

  • 介绍
  • 内部的
  • 外部的
    • 蜱虫
    • 跳蚤
    • 其他的

7. 动物寄生虫防治剂市场（依给药方式）

  • 介绍
  • 口服
  • 注射

第 8 章：动物寄生虫杀虫剂市场（依动物类型）

  • 介绍
  • 伴侣动物
  • 家畜
    • 牛
    • 家禽
    • 猪
    • 其他的

9. 动物寄生虫防治剂市场（按地区）

  • 介绍
  • 北美洲
    • 依产品类型
    • 依寄生虫类型
    • 按给药方式
    • 依动物类型
    • 按国家
      • 美国
      • 加拿大
      • 墨西哥
  • 南美洲
    • 依产品类型
    • 依寄生虫类型
    • 按给药方式
    • 依动物类型
    • 按国家
      • 巴西
      • 阿根廷
      • 其他的
  • 欧洲
    • 依产品类型
    • 依寄生虫类型
    • 按给药方式
    • 依动物类型
    • 按国家
      • 德国
      • 法国
      • 英国
      • 西班牙
      • 其他的
  • 中东和非洲
    • 依产品类型
    • 依寄生虫类型
    • 按给药方式
    • 依动物类型
    • 按国家
      • 沙乌地阿拉伯
      • 阿拉伯聯合大公国
      • 以色列
      • 其他的
  • 亚太地区
    • 依产品类型
    • 依寄生虫类型
    • 按给药方式
    • 依动物类型
    • 按国家
      • 中国
      • 印度
      • 日本
      • 韩国
      • 印尼
      • 泰国
      • 其他的

第十章竞争格局及分析

  • 主要企业和策略分析
  • 市场占有率分析
  • 合併、收购、协议和合作
  • 竞争对手仪表板

第十一章：公司简介

  • Boehringer Ingelheim GmbH
  • Elanco
  • Virbac Corporation
  • Merck & Co., Inc.
  • Zoetis
  • Vetoquinol SA
  • Ceva Sante Animale
  • Perrigo Company Plc,
  • Norbrook Laboratories
  • Bimeda Inc.

第十二章 附录

  • 货币
  • 先决条件
  • 基准年和预测年时间表
  • 相关人员的主要利益
  • 调查方法
  • 简称
简介目录
Product Code: KSI061611764

The animal parasiticides marketis expected to grow from USD13.190 billion in 2025 to USD17.251 billion in 2030, at a CAGR of 5.51%.

The animal parasiticides market is poised for significant growth from 2025 to 2030, driven by rising pet adoption, increasing animal health expenditure, and growing awareness of zoonotic diseases. Parasiticides, critical for managing ecto- and endoparasites in companion and agricultural animals, are seeing heightened demand due to their role in enhancing animal health and preventing disease transmission. The market benefits from innovations in product development and government initiatives promoting animal welfare, though stringent regulatory policies pose challenges.

Market Drivers

The primary driver of the animal parasiticides market is the global surge in pet adoption, particularly in urban areas, where companion animals like dogs and cats are increasingly valued. This trend has amplified the demand for effective parasiticides to ensure pet health and prevent diseases transmissible to humans. Rising animal health expenditure, especially in developed regions, further fuels market growth, as pet owners and livestock producers invest in advanced treatments to improve animal welfare. Growing awareness of animal-transmitted diseases, supported by initiatives from governments and animal welfare organizations, is another key factor. These campaigns emphasize the importance of parasiticides in controlling diseases caused by fleas, ticks, worms, and other parasites. Additionally, the development of innovative ectoparasiticides, designed to enhance disease management in companion animals, is driving market expansion by offering more effective and targeted solutions.

Market Restraints

The animal parasiticides market faces challenges due to stringent regulatory policies governing product approvals. These regulations, aimed at ensuring safety and efficacy, can delay market entry for new parasiticides, increasing development costs and timelines. Compliance with diverse regional standards further complicates market access for manufacturers, particularly smaller players. Additionally, the high cost of advanced parasiticides may limit adoption in price-sensitive markets, such as developing regions, where affordability is a key concern. Addressing these challenges through streamlined regulatory processes and cost-effective innovations will be essential for sustained market growth.

Market Segmentation

By Product Type

The market is segmented into ectoparasiticides, endoparasiticides, and endectocides. Ectoparasiticides, targeting external parasites like fleas and ticks, hold a significant share due to their widespread use in companion animals. Endoparasiticides, which address internal parasites like worms, are critical for both companion and agricultural animals. Endectocides, offering dual action against internal and external parasites, are gaining traction for their versatility and efficiency.

By Animal Type

The market serves companion animals (e.g., dogs, cats) and agricultural animals (e.g., cattle, poultry). The companion animal segment dominates, driven by rising pet ownership and increased spending on pet healthcare. The agricultural animal segment is also significant, as parasiticides are essential for maintaining livestock health and productivity, particularly in regions with intensive farming.

By Geography

The market is segmented into North America, Europe, Asia-Pacific, South America, and the Middle East and Africa. North America leads, driven by high animal health expenditure, particularly in the United States, and widespread pet adoption. The region's advanced veterinary infrastructure and effective disease management practices further support market dominance. Asia-Pacific is expected to grow rapidly, fueled by increasing pet ownership, rising livestock production, and growing awareness of zoonotic diseases in countries like China and India. Europe, South America, and the Middle East and Africa are also poised for growth, supported by improving veterinary services and regulatory frameworks.

Key Industry Players

The competitive landscape includes leading companies focused on innovation and market expansion. These players are investing in research and development to create advanced parasiticides and strengthen their market positions through strategic partnerships and product launches.

The animal parasiticides market is set for lucrative growth from 2025 to 2030, driven by rising pet adoption, increasing animal health expenditure, and growing awareness of zoonotic diseases. Despite challenges from stringent regulations and high costs, the market's outlook remains positive, particularly in North America and Asia-Pacific. Industry players must focus on innovative, cost-effective solutions and regulatory compliance to capitalize on the growing demand for parasiticides in both companion and agricultural animal sectors.

Key Benefits of this Report:

  • Insightful Analysis: Gain detailed market insights covering major as well as emerging geographical regions, focusing on customer segments, government policies and socio-economic factors, consumer preferences, industry verticals, and other sub-segments.
  • Competitive Landscape: Understand the strategic maneuvers employed by key players globally to understand possible market penetration with the correct strategy.
  • Market Drivers & Future Trends: Explore the dynamic factors and pivotal market trends and how they will shape future market developments.
  • Actionable Recommendations: Utilize the insights to exercise strategic decisions to uncover new business streams and revenues in a dynamic environment.
  • Caters to a Wide Audience: Beneficial and cost-effective for startups, research institutions, consultants, SMEs, and large enterprises.

What do businesses use our reports for?

Industry and Market Insights, Opportunity Assessment, Product Demand Forecasting, Market Entry Strategy, Geographical Expansion, Capital Investment Decisions, Regulatory Framework & Implications, New Product Development, Competitive Intelligence

Report Coverage:

  • Historical data from 2020 to 2024 & forecast data from 2025 to 2030
  • Growth Opportunities, Challenges, Supply Chain Outlook, Regulatory Framework, and Trend Analysis
  • Competitive Positioning, Strategies, and Market Share Analysis
  • Revenue Growth and Forecast Assessment of segments and regions including countries
  • Company Profiling (Strategies, Products, Financial Information, and Key Developments among others.

The animal parasiticides market is analyzed into the following segments:

By Product Type

  • Ectoparasiticides
  • Endoparasiticides
  • Endectocides

By Parasite Type

  • External
  • Internal

By Mode of Administration

  • Oral
  • Injectables

By Animal Type

  • Companion Animal
  • Livestock Animals

By Geography

  • North America
  • United States
  • Canada
  • Mexico
  • South America
  • Brazil
  • Argentina
  • Others
  • Europe
  • United Kingdom
  • Germany
  • France
  • Spain
  • Others
  • Middle East and Africa
  • Saudi Arabia
  • UAE
  • Israel
  • Others
  • Asia Pacific
  • Japan
  • China
  • India
  • South Korea
  • Indonesia
  • Thailand
  • Others

TABLE OF CONTENTS

1. EXECUTIVE SUMMARY

2. MARKET SNAPSHOT

  • 2.1. Market Overview
  • 2.2. Market Definition
  • 2.3. Scope of the Study
  • 2.4. Market Segmentation

3. BUSINESS LANDSCAPE

  • 3.1. Market Drivers
  • 3.2. Market Restraints
  • 3.3. Market Opportunities
  • 3.4. Porter's Five Forces Analysis
  • 3.5. Industry Value Chain Analysis
  • 3.6. Policies and Regulations
  • 3.7. Strategic Recommendations

4. TECHNOLOGICAL OUTLOOK

5. ANIMAL PARASITICIDES MARKET BY PRODUCT TYPE

  • 5.1. Introduction
  • 5.2. Ectoparasiticides
  • 5.3. Endoparasiticides
  • 5.4. Endectocides

6. ANIMAL PARASITICIDES MARKET BY PARASITE TYPE

  • 6.1. Introduction
  • 6.2. Internal
  • 6.3. External
    • 6.3.1. Ticks
    • 6.3.2. Fleas
    • 6.3.3. Others

7. ANIMAL PARASITICIDES MARKET BY MODE OF ADMINISTRATION

  • 7.1. Introduction
  • 7.2. Oral
  • 7.3. Injectable

8. ANIMAL PARASITICIDES MARKET BY ANIMAL TYPE

  • 8.1. Introduction
  • 8.2. Companion Animals
  • 8.3. Livestock Animals
    • 8.3.1. Cattle
    • 8.3.2. Poultry
    • 8.3.3. Swine
    • 8.3.4. Others

9. ANIMAL PARASITICIDES MARKET BY GEOGRAPHY

  • 9.1. Introduction
  • 9.2. North America
    • 9.2.1. By Product Type
    • 9.2.2. By Parasite Type
    • 9.2.3. By Mode of Administration
    • 9.2.4. By Animal Type
    • 9.2.5. By Country
      • 9.2.5.1. USA
      • 9.2.5.2. Canada
      • 9.2.5.3. Mexico
  • 9.3. South America
    • 9.3.1. By Product Type
    • 9.3.2. By Parasite Type
    • 9.3.3. By Mode of Administration
    • 9.3.4. By Animal Type
    • 9.3.5. By Country
      • 9.3.5.1. Brazil
      • 9.3.5.2. Argentina
      • 9.3.5.3. Others
  • 9.4. Europe
    • 9.4.1. By Product Type
    • 9.4.2. By Parasite Type
    • 9.4.3. By Mode of Administration
    • 9.4.4. By Animal Type
    • 9.4.5. By Country
      • 9.4.5.1. Germany
      • 9.4.5.2. France
      • 9.4.5.3. United Kingdom
      • 9.4.5.4. Spain
      • 9.4.5.5. Others
  • 9.5. Middle East and Africa
    • 9.5.1. By Product Type
    • 9.5.2. By Parasite Type
    • 9.5.3. By Mode of Administration
    • 9.5.4. By Animal Type
    • 9.5.5. By Country
      • 9.5.5.1. Saudi Arabia
      • 9.5.5.2. UAE
      • 9.5.5.3. Israel
      • 9.5.5.4. Others
  • 9.6. Asia Pacific
    • 9.6.1. By Product Type
    • 9.6.2. By Parasite Type
    • 9.6.3. By Mode of Administration
    • 9.6.4. By Animal Type
    • 9.6.5. By Country
      • 9.6.5.1. China
      • 9.6.5.2. India
      • 9.6.5.3. Japan
      • 9.6.5.4. South Korea
      • 9.6.5.5. Indonesia
      • 9.6.5.6. Thailand
      • 9.6.5.7. Others

10. COMPETITIVE ENVIRONMENT AND ANALYSIS

  • 10.1. Major Players and Strategy Analysis
  • 10.2. Market Share Analysis
  • 10.3. Mergers, Acquisitions, Agreements, and Collaborations
  • 10.4. Competitive Dashboard

11. COMPANY PROFILES

  • 11.1. Boehringer Ingelheim GmbH
  • 11.2. Elanco
  • 11.3. Virbac Corporation
  • 11.4. Merck & Co., Inc.
  • 11.5. Zoetis
  • 11.6. Vetoquinol S.A.
  • 11.7. Ceva Sante Animale
  • 11.8. Perrigo Company Plc,
  • 11.9. Norbrook Laboratories
  • 11.10. Bimeda Inc.

12. APPENDIX

  • 12.1. Currency
  • 12.2. Assumptions
  • 12.3. Base and Forecast Years Timeline
  • 12.4. Key Benefits for the Stakeholders
  • 12.5. Research Methodology
  • 12.6. Abbreviations